Results 131 to 140 of about 2,752 (153)
A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium. [PDF]
Diagnostics (Basel)Sawada E +6 more
europepmc +1 more source
Unmasking Hodgkin's Lymphoma and Its Mimics: Delving into the Interfollicular Zone Beyond Castleman's Disease. [PDF]
Indian J Surg OncolOsama MA +4 more
europepmc +1 more source
A Case of Idiopathic Multicentric Castleman's Disease Diagnosed From Anemia and Renal Dysfunction on an Annual Check-Up. [PDF]
CureusFukui S +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Hematology, 2007
Castleman disease was initially described over 50 years ago as a benign localized mass of lymph nodes found primarily in the mediastinum of asymptomatic patients. Subsequently, additional types were recognized that extend the spectrum of this heterogeneous group of diseases. Optimal standard therapies have not been established. Currently, most patients
Anu, Dham, Bruce A, Peterson
openaire +4 more sources
Castleman disease was initially described over 50 years ago as a benign localized mass of lymph nodes found primarily in the mediastinum of asymptomatic patients. Subsequently, additional types were recognized that extend the spectrum of this heterogeneous group of diseases. Optimal standard therapies have not been established. Currently, most patients
Anu, Dham, Bruce A, Peterson
openaire +4 more sources
RadioGraphics, 2023
Castleman disease (CD) is a group of rare and complex lymphoproliferative disorders that can manifest in two general forms: unicentric CD (UCD) and multicentric CD (MCD). These two forms differ in clinical manifestation, imaging appearances, treatment options, and prognosis.
Marika A. Pitot +9 more
openaire +2 more sources
Castleman disease (CD) is a group of rare and complex lymphoproliferative disorders that can manifest in two general forms: unicentric CD (UCD) and multicentric CD (MCD). These two forms differ in clinical manifestation, imaging appearances, treatment options, and prognosis.
Marika A. Pitot +9 more
openaire +2 more sources
Surgical Pathology Clinics, 2019
Castleman disease (CD) is divided clinically into unicentric or multicentric type. Pathologically, CD is divided into hyaline-vascular and plasma cell variants. Unicentric CD is most common, about 75% of these cases are hyaline-vascular variant, and surgical excision is often curative.
Wei, Wang, L Jeffrey, Medeiros
openaire +2 more sources
Castleman disease (CD) is divided clinically into unicentric or multicentric type. Pathologically, CD is divided into hyaline-vascular and plasma cell variants. Unicentric CD is most common, about 75% of these cases are hyaline-vascular variant, and surgical excision is often curative.
Wei, Wang, L Jeffrey, Medeiros
openaire +2 more sources
Castleman Disease Pathogenesis
Hematology/Oncology Clinics of North America, 2018Castleman disease (CD) describes a group of heterogeneous disorders with common lymph node histopathologic features, including atrophic or hyperplastic germinal centers, prominent follicular dendritic cells, hypervascularization, polyclonal lymphoproliferation, and/or polytypic plasmacytosis.
David C, Fajgenbaum, Dustin, Shilling
openaire +2 more sources
Treatment of castleman’s disease
Current Treatment Options in Oncology, 2005Castleman's disease (CD) was first described in 1954 and further defined in 1956 by Castleman. Since then much has been learned about the heterogeneity of this condition. Subsequently, three pathologic classifications have been developed (hyaline vascular variant, plasma cell variant, and mixed variant) and two clinical classifications (unicentric ...
Angela, Dispenzieri, Morie A, Gertz
openaire +2 more sources
Retroperitoneal Castleman's Disease
Urology, 2010A 56-year-old postmenopausal woman with a history of colon cancer status after left hemicolectomy presented to our institution with abdominal pain, early satiety, and weight loss. Computerized tomography scan showed a large, enhancing, fat-containing mass displacing the left kidney posteriolaterally suspicious for a retroperitoneal liposarcoma.
A Ari, Hakimi +3 more
openaire +2 more sources
Pathology of Castleman Disease
Hematology/Oncology Clinics of North America, 2018The term Castleman disease encompasses several distinct lymphoproliferative disorders with different underlying disease pathogenesis, and clinical outcomes. It includes unicentric and multicentric diseases with limited versus significant systemic symptoms, respectively.
David, Wu, Megan S, Lim, Elaine S, Jaffe
openaire +2 more sources